BTS Group AB (publ) (BTS-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 233.00 |
|---|---|
| 52-week range | 106.00 – 235.00 |
| Return, 1 month / 3 months | +11.8% / +25.0% |
| Return, 1 year / 3 years | +26.5% / −6.3% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 49.6% |
| Worst drawdown (1 year) | -43.4% |
| Average daily value traded | 5.18M SEK |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BTS Group is a Swedish consulting firm that helps organizations turn strategy into action. It designs and delivers customized business simulations, learning programs and leadership development experiences for corporate clients across many industries. Its work focuses on building business acumen and improving how teams execute strategic plans. The company is based in Stockholm, Sweden, and serves clients internationally through a network of offices.
On this site BTS Group AB (publ) appears as a stock on the Nasdaq Stockholm (Sweden), code BTS-B, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BTS Group AB (publ) (BTS-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 233.00 on 27 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 111 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.5% and over the last three months it rose 25.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 97 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 38.2% | ||
| From 52-week high | 0.0% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 25.0% | ||
| 6-month return | 57.2% | ||
| 12-month return, skipping the last month | 13.2% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.4% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 5.18M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | +11.8% |
| 3 months | +25.0% |
| 6 months | +57.2% |
| 1 year | +26.5% |
| 3 years | −6.3% |
| 5 years | −39.8% |
Signals
| 50-day / 200-day average | 207.48 / 168.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | SEK 2.2000 |
| 17 Nov 2025 | SEK 3.0500 |
| 19 May 2025 | SEK 3.0500 |
| 12 Nov 2024 | SEK 2.8500 |
| 6 May 2024 | SEK 2.8500 |
| 14 Nov 2023 | SEK 2.7000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.